PD
Therapeutic Areas
VicuTec Biologicals Pipeline
| Drug | Indication | Phase |
|---|---|---|
| COVID-19 Nanobody | COVID-19 | Pre-clinical |
| MRSA Nanobody | Methicillin-resistant Staphylococcus aureus infection | Pre-clinical |
| Tuberculosis Nanobody | Tuberculosis | Pre-clinical |
| Malaria Nanobody | Malaria | Pre-clinical |